These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 19197128)

  • 21. Emergence of 16S rRNA methylase gene armA and cocarriage of bla(IMP-1) in Pseudomonas aeruginosa isolates from South Korea.
    Gurung M; Moon DC; Tamang MD; Kim J; Lee YC; Seol SY; Cho DT; Lee JC
    Diagn Microbiol Infect Dis; 2010 Dec; 68(4):468-70. PubMed ID: 20926221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. bla(IMP-9) and its association with large plasmids carried by Pseudomonas aeruginosa isolates from the People's Republic of China.
    Xiong J; Hynes MF; Ye H; Chen H; Yang Y; M'zali F; Hawkey PM
    Antimicrob Agents Chemother; 2006 Jan; 50(1):355-8. PubMed ID: 16377710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of VIM-5 metallo-beta-lactamase in a Pseudomonas aeruginosa clinical isolate from Turkey.
    Bahar G; Mazzariol A; Koncan R; Mert A; Fontana R; Rossolini GM; Cornaglia G
    J Antimicrob Chemother; 2004 Jul; 54(1):282-3. PubMed ID: 15190017
    [No Abstract]   [Full Text] [Related]  

  • 24. The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.
    Zavascki AP; Barth AL; Gonçalves AL; Moro AL; Fernandes JF; Martins AF; Ramos F; Goldani LZ
    J Antimicrob Chemother; 2006 Aug; 58(2):387-92. PubMed ID: 16751638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.
    Juan C; Zamorano L; Mena A; Albertí S; Pérez JL; Oliver A
    J Antimicrob Chemother; 2010 Mar; 65(3):474-8. PubMed ID: 20071364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrence of antipseudomonal beta-lactams and aminoglycosides resistance in Pseudomonas aeruginosa during therapy.
    Pagani L; Scarabelli M; Cereda PM; Debiaggi M
    Microbiologica; 1987 Jan; 10(1):103-10. PubMed ID: 3106759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Occurrence of multiresistant strains of Pseudomonas aeruginosa producing metallo-beta-lactamase blaSPM-1 in clinical samples].
    Gräf T; Fuentefria DB; Corção G
    Rev Soc Bras Med Trop; 2008; 41(3):306-8. PubMed ID: 18719815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of multidrug-resistant and metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from a paediatric clinic in China.
    Dong F; Xu XW; Song WQ; Lü P; Yu SJ; Yang YH; Shen XZ
    Chin Med J (Engl); 2008 Sep; 121(17):1611-6. PubMed ID: 19024085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of genetic determinants involved in beta-lactam- and multiresistance in a surgical ICU.
    van Loon HJ; Box AT; Verhoef J; Fluit AC
    Int J Antimicrob Agents; 2004 Aug; 24(2):130-4. PubMed ID: 15288311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).
    Dubois V; Arpin C; Dupart V; Scavelli A; Coulange L; André C; Fischer I; Grobost F; Brochet JP; Lagrange I; Dutilh B; Jullin J; Noury P; Larribet G; Quentin C
    J Antimicrob Chemother; 2008 Aug; 62(2):316-23. PubMed ID: 18467306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pseudomonas aeruginosa beta-lactamases.
    Savoia D; Gribaudo GM; Angeretti A; Negro Ponzi A
    Boll Ist Sieroter Milan; 1983; 62(6):489-494. PubMed ID: 6428432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan.
    Yan JJ; Tsai SH; Chuang CL; Wu JJ
    J Microbiol Immunol Infect; 2006 Apr; 39(2):130-4. PubMed ID: 16604245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-level expression of IMP-5 carbapenemase owing to point mutation in the -35 promoter region of class 1 integron among Pseudomonas aeruginosa clinical isolates.
    Brízio A; Conceição T; Pimentel M; Da Silva G; Duarte A
    Int J Antimicrob Agents; 2006 Jan; 27(1):27-31. PubMed ID: 16359846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial susceptibility and ESBL prevalence in Pseudomonas aeruginosa isolated from burn patients in the North West of Pakistan.
    Ullah F; Malik SA; Ahmed J
    Burns; 2009 Nov; 35(7):1020-5. PubMed ID: 19501980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mechanisms of pandrug-resistance of Pseudomonas aeruginosa].
    Shen JL; Zhu DM; Wang MG
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1859-62. PubMed ID: 19040025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species.
    Gupta V
    Expert Opin Investig Drugs; 2008 Feb; 17(2):131-43. PubMed ID: 18230049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia.
    Tam VH; Chang KT; Schilling AN; LaRocco MT; Genty LO; Garey KW
    Diagn Microbiol Infect Dis; 2009 Mar; 63(3):279-85. PubMed ID: 19135330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First report of the carbapenem-resistant Pseudomonas aeruginosa producing IMP-7 metallo-beta-lactamase in Slovakia.
    Ohlasova D; Kmet V; Niks M
    Int J Antimicrob Agents; 2007 Oct; 30(4):370-1. PubMed ID: 17709230
    [No Abstract]   [Full Text] [Related]  

  • 39. Evolution of extended-spectrum beta-lactamases in a MutS-deficient Pseudomonas aeruginosa hypermutator.
    Driffield KL; Bostock JM; Miller K; O'neill AJ; Hobbs JK; Chopra I
    J Antimicrob Chemother; 2006 Oct; 58(4):905-7. PubMed ID: 16901912
    [No Abstract]   [Full Text] [Related]  

  • 40. Occurrence and mechanisms of amikacin resistance and its association with beta-lactamases in Pseudomonas aeruginosa: a Korean nationwide study.
    Kim JY; Park YJ; Kwon HJ; Han K; Kang MW; Woo GJ
    J Antimicrob Chemother; 2008 Sep; 62(3):479-83. PubMed ID: 18606785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.